» Articles » PMID: 32484699

Death-inducer Obliterator 1 (DIDO1) Silencing Suppresses Growth of Bladder Cancer Cells Through Decreasing SAPK/JNK Signaling Cascades

Overview
Journal Neoplasma
Specialty Oncology
Date 2020 Jun 3
PMID 32484699
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Death inducer obliterator (DIDO) is involved in apoptosis and embryonic stem cell self-renewal. Here, we investigate the effect of DIDO1 on bladder cancer cells and clarify the underlying molecular mechanism. Bladder cancer tissues and cell lines (T24, ScaBER, 5637), as well as normal bladder epithelial cells (SV-HUC-1), were used to measure the levels of DIDO1 mRNA and protein by qRT-PCR and western blot, respectively. The results indicated that DIDO1 was highly expressed in bladder cancer tissues and cell lines. And the expression of DIDO1 in T24 and 5637 cells was higher than that in ScaBER and SV-HUC-1 cells. The expression of DIDO1 was knocked down in T24 and 5637 cells by infection with shDIDO1-1 and shDIDO1-2 lentivirus. The growth of T24 and 5637 cells was monitored using Celigo, MTT assays, and colony formation assay. Apoptosis was examined by flow cytometric analysis. The effect of DIDO1 knockdown on tumorigenesis of T24 xenograft tumors was determined in nude mice. Reduction of DIDO1 mRNA resulted in reduced proliferation, decreased cell colony formation, increased apoptosis in vitro, and inhibited tumorigenesis in vivo. Furthermore, we identified signaling molecules involved in stress and apoptosis using the PathScan Antibody Array Kit and western blot. The depletion of DIDO1 significantly decreased the levels of phosphorylated SAPK/JNK, and Chk1/2, as well as the upregulating cleaved Caspase-7 expression. These results indicated that the potential mechanism of DIDO1 action might involve SAPK/JNK signaling cascades.

Citing Articles

Detection of endometrial cancer using tampon-based collection and methylated DNA markers.

Bakkum-Gamez J, Sherman M, Slettedahl S, Mahoney D, Lemens M, Laughlin-Tommaso S Gynecol Oncol. 2023; 174:11-20.

PMID: 37141817 PMC: 10330802. DOI: 10.1016/j.ygyno.2023.04.014.


Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells.

Quintela M, James D, Pociute A, Powell L, Edwards K, Coombes Z Clin Epigenetics. 2023; 15(1):63.

PMID: 37060086 PMC: 10105475. DOI: 10.1186/s13148-023-01477-x.


SPOC domain proteins in health and disease.

Appel L, Benedum J, Engl M, Platzer S, Schleiffer A, Strobl X Genes Dev. 2023; 37(5-6):140-170.

PMID: 36927757 PMC: 10111866. DOI: 10.1101/gad.350314.122.


MAPKAPK2-centric transcriptome profiling reveals its major role in governing molecular crosstalk of IGFBP2, MUC4, and PRKAR2B during HNSCC pathogenesis.

Soni S, Anand P, Swarnkar M, Patial V, Tirpude N, Padwad Y Comput Struct Biotechnol J. 2023; 21:1292-1311.

PMID: 36817960 PMC: 9929207. DOI: 10.1016/j.csbj.2023.01.039.


In leukemia, knock-down of the death inducer-obliterator gene would inhibit the proliferation of endothelial cells by inhibiting the expression of and .

Cao H, Wang L, Geng C, Yang M, Mao W, Yang L PeerJ. 2022; 10:e12832.

PMID: 35178295 PMC: 8815367. DOI: 10.7717/peerj.12832.